Evidence map›Paper›PMID 29108258›Full record

ArticleOncotarget2017

Transcriptional signature of lymphoblastoid cell lines of

Marie-Christine Pouliot, Charu Kothari, Charles Joly-Beauparlant, Yvan Labrie, Geneviève Ouellette, Jacques Simard, Arnaud Droit, Francine Durocher

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Bayesian combinatorial MultiStudy factor analysis.The annals of applied statistics · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. An isoform of AIF1 involved in breast cancer.Cancer cell international · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marie-Christine PouliotCHU de Québec Research Centre-Université Laval, Department of Molecular Medicine, Québec, Canada.
Charu KothariCHU de Québec Research Centre-Université Laval, Department of Molecular Medicine, Québec, Canada.
Charles Joly-BeauparlantCHU de Québec Research Centre-Université Laval, Department of Molecular Medicine, Québec, Canada.
Yvan LabrieCHU de Québec Research Centre-Université Laval, Department of Molecular Medicine, Québec, Canada.
Geneviève OuelletteCHU de Québec Research Centre-Université Laval, Department of Molecular Medicine, Québec, Canada.
Jacques SimardCHU de Québec Research Centre-Université Laval, Department of Molecular Medicine, Québec, Canada.
Arnaud DroitCHU de Québec Research Centre-Université Laval, Department of Molecular Medicine, Québec, Canada.
Francine DurocherCHU de Québec Research Centre-Université Laval, Department of Molecular Medicine, Québec, Canada.
Université Laval · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Approximately 25% of hereditary breast cancer cases are associated with a strong familial history which can be explained by mutations in

Indexed as

gene expressionhereditary breast cancerhigh-risk BRCA1/2/X familieslymphoblastoid cell linesRNA-seq

Identifiers

PMID29108258
PMCPMC5667991
OpenAlexW2743111741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.